N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection Fraction

Sponsor: Peking University Third Hospital • ClinicalTrials.gov ID: NCT07693049

Registry updated: 2026-09-30
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Cardiovascular-Kidney-Metabolic (CKM) Syndrome is a continuous clinical disease spectrum integrating cardiovascular, renal, and metabolic disorders. Heart failure with preserved ejection fraction (HFpEF) is considered Stage 4 of CKM syndrome, characterized primarily by impairment of cardiac structure and function. Numerous studies have confirmed that exercise intervention is effective in improving metabolic profiles and inflammatory status in Stages 0-3 of CKM syndrome (e.g., obesity, metabolic syndrome, hypertension, and diabetes), and significantly improves clinical outcomes. However, for Stage 4 CKM syndrome, especially in patients with HFpEF, conventional exercise prescription faces significant challenges in balancing safety and efficacy. Moreover, traditional "one-size-fits-all" exercise rehabilitation strategies have failed to significantly improve clinical outcomes due to the lack of individualized precision approaches. To address this gap, this study proposes to adopt a multicenter, randomized, controlled design, enrolling patients with HFpEF at Stage 4 of CKM syndrome and randomly assigning them to either a personalized high-intensity interval training (HIIT) intervention group or a standard care control group. The \*\*primary endpoint\*\* of this study is the change in peak oxygen consumption (peak VO₂) from baseline after 24 weeks of intervention. In addition, a series of \*\*secondary endpoints\*\* have been established for comprehensive evaluation, including inflammatory biomarkers, cardiac structure and function, quality of life, and composite clinical events. These endpoints aim to comprehensively assess the intervention effects from the perspectives of cardiopulmonary function, metabolism and inflammation, quality of life, and clinical outcomes, as well as to explore the underlying mechanisms. This study is expected to validate the beneficial effects of personalized exercise on peak VO₂ and various secondary endpoints in patients with Stage 4 CKM syndrome. It will not only provide high-level evidence-based support for exercise therapy in HFpEF but also deepen the understanding of the role of exercise intervention in the full-course management of CKM syndrome, offering key scientific support for the development of precision prevention and treatment strategies across all stages.

Interventions

  • High-intensity interval training (Behavioral)
    Subjects in the intervention group will receive a personalized high-intensity interval training (HIIT) protocol based on cardiopulmonary exercise testing (CPET) and will undergo a 24-week HIIT intervention, four times per week.The exercise protocol consisted of a 5-minute warm-up at 30-40 watts, followed by 8 cycles of high-intensity exercise performed at 80-90% of peak VO₂ for 30 seconds, each interspersed with a 60-second active recovery period of low-intensity exercise at 50-60% of peak VO₂ , and concluded with a 5-minute cool-down at 30-40 watts.

Eligibility criteria

Inclusion Criteria: 1. Men and women aged 35-70 years; 2. Physical inactivity / sedentary lifestyle defined as: Sedentary behavior: average daily sitting time \> 6 hours over the past 6 months; AND/OR Insufficient physical activity: average weekly moderate-intensity physical activity \< 150 minutes or vigorous-intensity physical activity \< 75 minutes as assessed by the International Physical Activity Questionnaire (IPAQ); 3. Patients with HFpEF at Stage 4 of CKM syndrome who have been clinically stable within the past month (New York Heart Association \[NYHA\] functional class II-III); 4. Willingness to improve health status through appropriate exercise. Exclusion Criteria: 1. Presence of contraindications to cardiopulmonary exercise testing (CPET); 2. Positive findings on the exercise electrocardiogram (ECG) during CPET; 3. Diagnosis of psychiatric disorders; 4. Presence of movement disorders or lower extremity exercise-related injuries within the past 6 months; 5. Women who are pregnant, breastfeeding, or planning to become pregnant in the near future; 6. Other conditions deemed unsuitable for participation in this study by the investigators; 7. Refusal to sign the informed consent form.

Conditions

HFpEF - Heart Failure With Preserved Ejection Fraction

Locations

  • Beijing Chao-Yang Hospital, Capital Medical University — Beijing, China
  • Beijing Hospital — Beijing, China
  • Beijing Xiaotangshan Hospital — Beijing, China
  • Beijing Zhongguancun Hospital — Beijing, China
  • Community Health Station of the Party School of the Central Committee of C.P.C — Beijing, China
  • Jimenli Community Health Service Center — Beijing, China
  • Peking University First Hospital — Beijing, China
  • Peking University People's Hospital — Beijing, China
  • Peking University Third Hospital — Beijing, China
  • Xueyuanlu Community Health Service Center — Beijing, China
  • Qingdao Municipal Hospital — Qingdao, China
  • Shanghai East Hospital — Shanghai, China
  • Wuhan Asia Heart Hospital — Wuhan, China
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record